Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 3/20 | 0.86 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.71 |
| ▸ | PIM1 | P11309 | 2/20 | 0.71 |
| ▸ | CD38 | P28907 | 2/20 | 0.71 |
| ▸ | TUBB4A | P04350 | 4/20 | 0.70 |
| ▸ | TUBB | P07437 | 4/20 | 0.70 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.70 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.70 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.70 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.70 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.70 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.70 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.70 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.70 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.70 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.70 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.70 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.70 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.70 |
| ▸ | NR0B1 | P51843 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Patuletin SCHEMBL29929679 | 1.00 | XDH (0.86) | XDHAMY1APIM1CD38TUBB4A | |
| Patuletin SCHEMBL29929193 | 1.00 | XDH (0.86) | XDHAMY1APIM1CD38TUBB4A | |
| Axillarin SCHEMBL29929599 | 0.92 | XDH (1.00) | XDHAMY1ATUBB4ATUBBTUBA3C | |
| Axillarin SCHEMBL1155670 | 0.92 | XDH (1.00) | XDHAMY1ATUBB4ATUBBTUBA3C | |
| Axillarin SCHEMBL29929648 | 0.92 | XDH (1.00) | XDHAMY1ATUBB4ATUBBTUBA3C | |
| SCHEMBL19461012 | 0.90 | TUBB4A (0.74) | XDHTUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL29647956 | 0.90 | TUBB4A (0.74) | XDHTUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL31058466 | 0.90 | MKNK2 (0.86) | XDHMKNK2NOX4ALOX5ABCB1 | |
| SCHEMBL29143220 | 0.90 | MKNK2 (0.86) | XDHMKNK2NOX4ALOX5ABCB1 | |
| SCHEMBL31675806 | 0.88 | TUBB4A (0.71) | XDHPIM1TUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137745-A1 | QUERCETAGETIN ENRICHED MARIGOLD EXTRACTS, COMPOSITIONS, METHODS OF PREPARATION AND USE THEREOF | AVT NATURAL PRODUCTS LTD (IN) | 2026-05-21 | — | — | US | claimed |
| US-12514266-B2 | Composition containing quercetagetin | CHENGUANG BIOTECH GROUP CO., LTD. (CN) | 2026-01-06 | — | — | US | claimed |
| US-20250257032-A1 | METHOD OF PREPARING HIGH PURITY LUTEIN ESTER CRYSTALS, AND APPLICATIONS THEREOF | AVT NATURAL PRODUCTS LTD. (IN) | 2025-08-14 | — | — | US | claimed |
| CN-120195403-A | Screening method of targeted CD276 small molecule inhibitor and anti-tumor application thereof | 郑州大学 | 2025-06-24 | — | — | CN | claimed |
| WO-2025071391-A1 | LIPID-BASED TOPICAL OPHTHALMIC FORMULATION FOR ENHANCING THE EFFICIENCY OF THE PENETRATION OF THE EYEBALL BARRIER BY THE BIOACTIVES PILOCARPINE, THE COUMARIN SCOPOLETIN AND PATULETIN PRESENT IN PILOCARPUS JABORANDI EXTRACT AND USE THEREOF IN PRESERVING LENS HEALTH | CENTRO DE RETINA MÉDICA Y QUIRÚRGICA, S.C. (MX) | 2025-04-03 | — | — | WO | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2024084504-A2 | QUERCETAGETIN ENRICHED MARIGOLD EXTRACTS, COMPOSITIONS, METHODS OF PREPARATION AND USE THEREOF | AVT NATURAL PRODUCTS LTD. (IN) | 2024-04-25 | — | — | WO | claimed |
| US-20230119060-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE | MEDIENCE CO., LTD. (KR) | 2023-04-20 | — | — | US | claimed |
| US-20230122252-A1 | COMPOSITION CONTAINING QUERCETAGETIN | CHENGUANG BIOTECH GROUP CO., LTD. (CN) | 2023-04-20 | — | — | US | claimed |
| US-20090054517-A1 | Phytoestrogens As Regulators Of Hedgehog Signaling And Methods Of Their Use In Cancer Treatment | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-02-26 | — | — | US | claimed |
| WO-2008131354-A2 | PHYTOESTROGENS AS REGULATORS OF HEDGEHOG SIGNALING AND METHODS OF THEIR USE IN CANCER TREATMENT | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2008-10-30 | — | — | WO | claimed |
| CN-101119719-A | The use of flavonol and flavonol glycosides for stimulating growth of renal tubular epithelial cells to secrete the kidney secreting bone growth factor | MIAN LONG (US) | 2008-02-06 | — | — | CN | claimed |
| CN-101091706-A | Excitant of dopamine transport protein and usage | HEHONG BIOTECH SHANGHAI CO LTD (CN) | 2007-12-26 | — | — | CN | claimed |
| EP-1847265-A1 | THE USE OF FLAVONOL AND FLAVONOL GLYCOSIDES FOR STIMULATING GROWTH OF RENAL TUBULAR EPITHELIAL CELLS TO SECRETE THE KIDNEY SECRETING BONE GROWTH FACTOR | Long, Mian (US) | 2007-10-24 | — | — | EP | claimed |
| CN-101019557-A | Recipe and prepn of botanical composite pesticide | BEIJING TIANDILUYUAN INST OF A (CN) | 2007-08-22 | — | — | CN | claimed |
| CN-1742983-A | Composition containing herbal medicine component for promoting absorption and production method thereof | OSHIRO KIYOTOSHI (JP) | 2006-03-08 | — | — | CN | claimed |
| EP-0868914-B1 | USE OF A FLAVONOID-CONTAINING EXTRACT OF THE PLANT EUPHORBIA PROSTRATA IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF AN ANORECTIC OR COLONIC DISEASE | PANACEA BIOTEC LTD (IN) | 2002-12-18 | — | — | EP | claimed |
| US-5858371-A | Pharmaceutical composition for the control and treatment of anorectal and colonic diseases | PANACEA BIOTECH LIMITED (IN) | 1999-01-12 | — | — | US | claimed |
| EP-0868914-A1 | Pharmaceutical composition for the control and treatment of anorectal and colonic diseases | PANACEA BIOTEC LIMITED (IN) | 1998-10-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230119060-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE | SLC5A2, SLC5A1, SLC5A6 | XDH 2936/4885AMY1A 2463/4885PIM1 3429/4885 |
| US-20260137745-A1 | QUERCETAGETIN ENRICHED MARIGOLD EXTRACTS, COMPOSITIONS, METHODS OF PREPARATION AND USE THEREOF | LIPA, LIPC, CUTA | XDH 990/4885AMY1A 50/4885PIM1 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.